Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 79

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 79
---
 officer was unavailable, the chief financial officer, under our 2023 Stock Incentive Plan, effective on the first trading day of the month following the month in which the employee is hired. If stock options are granted in connection with promotions or for retention purposes, such grants are also typically pursuant to delegated authority and are effective on 58 February 1 stof each year or on the first trading day of the month following the related event. Our chief executive officer and chief financial officer do not take into account material nonpublic information when determining the timing or terms of such stock option grants. Under our non-employeedirector compensation policy, the grants of annual stock options to non-employeedirectors serving at time of our annual meeting of stockholders are effective immediately following such annual meeting of our stockholders. Under our non-employeedirector compensation policy, our board of directors grants stock options to new non-employeedirectors effective upon the director’s initial election to our board of directors. During the year ended December 31, 2024, we did not grant stock options to any named executive officer during any period beginning four business days before and ending one business day after the filing of any Form 10-Qor 10-K,or the filing or furnishing of a Form 8-Kthat discloses material nonpublic information. 59

Clawback Policy Effective October 2, 2023, we adopted a compensation recovery policy, or a “clawback policy”, in accordance with Rule 10D-1under the Exchange Act, or Rule 10D-1,and Nasdaq Listing Rule 5608. The policy is administered by the compensation & people committee. The policy provides that, in the event that we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under U.S. federal securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, we will attempt to recover, reasonably promptly from each covered executive, any erroneously awarded incentive-based compensation received by our covered executives during the recovery period under the policy. For purposes of this policy, covered executives means any executive officer (as defined in Rule 16a-1(f)under the Exchange Act) who served at any time during the performance period for the applicable incentive-based compensation. In